Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas Leichsenring

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
European Urology Focus|December 17, 2019
The Value of Prostate-specific Antigen Density for Prostate Imaging-Reporting and Data System 3 Lesions on Multiparametric Magnetic Resonance Imaging: A Strategy to Avoid Unnecessary Prostate BiopsiesMagdalena Görtz, Jan Philipp Radtke, Gencay Hatiboglu, et al.
Genes, Chromosomes & Cancer|June 23, 2017
Mutational profiles of Brenner tumors show distinctive features uncoupling urothelial carcinomas and ovarian carcinoma with transitional cell histologyNicole Pfarr, Silvia Darb-Esfahani, Jonas Leichsenring, et al.
Der Pathologe|May 3, 2021
[Variant interpretation in molecular pathology and oncology : An introduction]Peter Horak, Jonas Leichsenring, Simon Kreutzfeldt, et al.
Der Pathologe|October 4, 2021
Peter Horak, Jonas Leichsenring, Simon Kreutzfeldt, et al.
Genes, Chromosomes & Cancer|October 18, 2016
Synonymous EGFR variant p.Q787Q is neither prognostic nor predictive in patients with lung adenocarcinomaJonas Leichsenring, Anna-Lena Volckmar, Nikolaus Magios, et al.
Genes, Chromosomes & Cancer|October 19, 2017
Targeted deep sequencing of effusion cytology samples is feasible, informs spatiotemporal tumor evolution, and has clinical and diagnostic utilityJonas Leichsenring, Anna-Lena Volckmar, Martina Kirchner, et al.
Frontiers in Immunology|February 2, 2023
Virotherapy combined with anti-PD-1 transiently reshapes the tumor immune environment and induces anti-tumor immunity in a preclinical PDAC modelRūta Veinalde, Gemma Pidelaserra-Martí, Coline Moulin, et al.
Proteomics. Clinical Applications|July 24, 2018
Combined Immunohistochemistry after Mass Spectrometry Imaging for Superior Spatial InformationKatharina Kriegsmann, Rémi Longuespée, Michael Hundemer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 12, 2019
Patients Resistant Against PSMA-Targeting α-Radiation Therapy Often Harbor Mutations in DNA Damage-Repair-Associated GenesClemens Kratochwil, Frederik L Giesel, Claus-Peter Heussel, et al.
Pathology|December 23, 2017
Targeted molecular profiling reveals genetic heterogeneity of poromas and porocarcinomasMartina Bosic, Martina Kirchner, Dimitrije Brasanac, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
European Urology Focus|December 17, 2019
The Value of Prostate-specific Antigen Density for Prostate Imaging-Reporting and Data System 3 Lesions on Multiparametric Magnetic Resonance Imaging: A Strategy to Avoid Unnecessary Prostate BiopsiesMagdalena Görtz, Jan Philipp Radtke, Gencay Hatiboglu, et al.
Genes, Chromosomes & Cancer|June 23, 2017
Mutational profiles of Brenner tumors show distinctive features uncoupling urothelial carcinomas and ovarian carcinoma with transitional cell histologyNicole Pfarr, Silvia Darb-Esfahani, Jonas Leichsenring, et al.
Der Pathologe|May 3, 2021
[Variant interpretation in molecular pathology and oncology : An introduction]Peter Horak, Jonas Leichsenring, Simon Kreutzfeldt, et al.
Der Pathologe|October 4, 2021
Peter Horak, Jonas Leichsenring, Simon Kreutzfeldt, et al.
Genes, Chromosomes & Cancer|October 18, 2016
Synonymous EGFR variant p.Q787Q is neither prognostic nor predictive in patients with lung adenocarcinomaJonas Leichsenring, Anna-Lena Volckmar, Nikolaus Magios, et al.
Genes, Chromosomes & Cancer|October 19, 2017
Targeted deep sequencing of effusion cytology samples is feasible, informs spatiotemporal tumor evolution, and has clinical and diagnostic utilityJonas Leichsenring, Anna-Lena Volckmar, Martina Kirchner, et al.
Frontiers in Immunology|February 2, 2023
Virotherapy combined with anti-PD-1 transiently reshapes the tumor immune environment and induces anti-tumor immunity in a preclinical PDAC modelRūta Veinalde, Gemma Pidelaserra-Martí, Coline Moulin, et al.
Proteomics. Clinical Applications|July 24, 2018
Combined Immunohistochemistry after Mass Spectrometry Imaging for Superior Spatial InformationKatharina Kriegsmann, Rémi Longuespée, Michael Hundemer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 12, 2019
Patients Resistant Against PSMA-Targeting α-Radiation Therapy Often Harbor Mutations in DNA Damage-Repair-Associated GenesClemens Kratochwil, Frederik L Giesel, Claus-Peter Heussel, et al.
Pathology|December 23, 2017
Targeted molecular profiling reveals genetic heterogeneity of poromas and porocarcinomasMartina Bosic, Martina Kirchner, Dimitrije Brasanac, et al.
Pageof 5